Table 1 Correlations between WFDC3 expression and clinicopathological characteristics in CRC patients.

From: WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer

Variables

Cases

WFDC3 expression

 
  

Positive

Negative

P-value

Age (years)

   

0.984

 ≤60

102

49

53

 

 >60

71

34

37

 

Gender

   

0.867

 Male

72

34

38

 

 Female

101

49

52

 

Tumor location

   

0.123

 Colon

98

42

56

 

 Rectum

75

41

34

 

Tumor size (cm)

   

0.513

 ≤4

104

52

52

 

 >4

69

31

38

 

Depths of invasion

   

0.252

 T1/T2

20

12

8

 

 T3/T4

153

71

82

 

Lymph node metastasis

   

0.007

 Negative

48

31

17

 

 Positive

125

52

73

 

Distance metastasis

   

0.005

 Negative

104

59

45

 

 Positive

69

24

45

 

TNM stage

   

0.015

 I/II

96

54

42

 

 III/ IV

77

29

48

 

Differentiation

   

0.073

 Well

2

1

1

 

 Moderate

126

67

59

 

 Poor

45

15

30

 
  1. Statistical significance was determined by Pearson χ2‐test, P-values in bold were statistically significant.
Back to article page